Efficacy and Safety of Two Doses of HIL-214 in Children

NCT05281094 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

3084

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Gastroenteritis

Interventions

BIOLOGICAL: HIL-214
BIOLOGICAL: Placebo

Sponsor

HilleVax